Planet 13 Holdings (PLNH) Long-Term Deferred Tax (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Long-Term Deferred Tax came in at $1.8 million in Q1 2026, up 38.93% year-on-year from $1.3 million in Q1 2025, and down 0.83% on a QoQ basis from $1.8 million in Q4 2025.
Planet 13 Holdings (PLNH) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Long-Term Deferred Tax data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Long-Term Deferred Tax rose 38.93% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 38.93% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 100.63% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $1.8 million, down from $1.8 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for PLNH reached as high as $2.4 million in Q3 2025 and fell as low as $174157.0 in Q1 2022.
- Historically, Long-Term Deferred Tax has averaged $849800.2 across 5 years, with a median of $725196.0 in 2024.
- Across the five-year window, Long-Term Deferred Tax grew 26.98% in 2024 and surged 227.17% in 2025, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $346257.0 in 2022, then surged by 103.91% to $706038.0 in 2023, then advanced by 26.98% to $896525.0 in 2024, then surged by 100.63% to $1.8 million in 2025, then slipped by 0.83% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $1.8 million in Q1 2026, $1.8 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 896,525.00 |
| Sep 30, 2024 | 729,435.00 |
| Jun 30, 2024 | 747,619.00 |
| Mar 31, 2024 | 725,196.00 |
| Dec 31, 2023 | 706,038.00 |
| Sep 30, 2023 | 350,001.00 |
| Jun 30, 2023 | 318,294.00 |
| Mar 31, 2023 | 276,088.00 |
| Dec 31, 2022 | 346,257.00 |
| Sep 30, 2022 | 206,421.00 |
| Jun 30, 2022 | 190,432.00 |
| Mar 31, 2022 | 174,157.00 |
| Dec 31, 2021 | 162,804.00 |